Science Videos

from AP, Reuters, AFP, and other news services

Could HIV Drugs Be The Key To Treating Multiple Sclerosis?

Date:
August 5, 2014
Source:
Newsy / Powered by NewsLook.com
Summary:
A study published in the Journal of Neurology, Neurosurgery & Psychiatry found people with HIV have a lower risk of developing multiple sclerosis. Video provided by Newsy


Related Videos

last updated on 2014-11-25 at 10:12 pm EST

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
Romanian Bees Still Creating a Buzz in Health Industry

Romanian Bees Still Creating a Buzz in Health Industry

AFP (Apr. 9, 2014) — Bee venom to combat multiple sclerosis, pollen for indigestion, honey to heal wounds - the bee has been a key source of alternative medicines since ancient times, and Romania is working to keep the tradition of "apitherapy" alive. Duration: 02:30 Video provided by AFP
Powered by NewsLook.com
Single Dose HIV Drug Launched

Single Dose HIV Drug Launched

AFP (Apr. 8, 2013) — South Africa's health minister launches a new single dose anti-AIDS drug, which reduces the need for HIV positive patients to take multiple pills each day. The country has the largest HIV positive population in the world.
Powered by NewsLook.com
MS Blocked Vein Theory Disputed in Canadian Study

MS Blocked Vein Theory Disputed in Canadian Study

CBC (Aug. 14, 2013) — A Canadian study of 100 multiple sclerosis patients offers "compelling evidence" against the controversial idea that blocked veins in the head and neck are involved in the disease.
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins